Together, We’re the Power Behind the Cure!
HALT GENETIC KIDNEY DISEASE IN ITS TRACKS
Learn more about RKDF’s efforts to spread the word about Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD); encourage genetic testing for its most common subtypes, MUC1 and UMOD; and build a supportive community of patients, families, and the medical professionals who treat them.
Genetic testing Available
Join us in our mission to raise awareness about ADTKD and encourage genetic testing in an effort to help pave the way for new treatments and bring HOPE to potentially over 1 million people worldwide.
-
Patient Stories
Learn how these families discovered that their family history of chronic kidney disease was the result of MUC1 or UMOD and how they are faring.
-
Events
View our upcoming and past events.
Building a supportive community of patients, families, and the medical professionals who treat them.
-
Donate
Your donations help us spread the word about ADTKD and about game-changing treatments on the horizon, thereby providing HOPE to ADTKD patients and improving patient care by nephrologists.
Did you know?
Did you know that up to 10% of all chronic kidney disease (CKD) patients in the U.S. – as many as 3.5 million people – have a genetic mutation that causes their disease? This staggering number includes an estimated 40% of dialysis patients who, along with their nephrologists, are in the dark about the cause of their kidney failure.
Fortunately, the genetic causes of many kidney diseases have been identified, paving the way for the discovery of new treatments.
A breakthrough therapy is on the horizon
There is much HOPE around promising drug-like compounds that may HALT the devastating impacts of MUC1 and UMOD.
There is much HOPE around a promising drug-like compounds that may HALT the devastating impacts of MUC1 and UMOD.
Listen to Dr. Anna Greka from Harvard Medical School and The Broad Institute of MIT and Harvard describe this scientific breakthrough in her 13-minute TED Talk from April 2023, and learn more about her research here.